BOSTON CHILDREN'S HOSPITAL

Funding Organization

Awards Grant

  • A Phase 3 Study of Eltrombopag vs Standard First-Line Management for Newly-Diagnosed Immune Thrombocytopenia (ITP) in Children
  • Advancing Transplantation Outcomes in Children
  • Advancing Transplantation Outcomes in Children (Clinical Study)
  • Advancing Transplantation Outcomes in Children (Mechanistic Study)
  • Deep Phenotyping of Reportable Cancer Recurrence
  • Development of the CF Stress Questionnaire: Testing and Validation
  • Developmental Synaptopathies Associated with TSC, PTEN and SHANK3 Mutations (Cost Reimbursable)
  • Developmental Synaptopathies Associated with TSC, PTEN and SHANK3 Mutations (TSC; Enrollment)
  • Feasibility of A Mobile Medication Plan Application in CF Patient Care
  • Immunobiology of Influenza Virus-Related Critical Illness in Young Hosts (PICFLU2)
  • Influenza Vaccine Effectiveness for Preventing Laboratory-Confirmed Severe Influenza Associated Illness in US Children (PICFLU-VE)
  • Molecular Mechanisms Governing Vascular Cell Function and Phenotype in Health and Disease
  • NAPAAC Registry Study of Bone Marrow Failure and Myelodysplastic Syndromes
  • Prospective Multisite Study of Quality of Life in Pediatric Intestinal Failure
  • Quality Improvement Pathway for Newly Diagnosed Immune Thrombocytopenia in Children
  • Research Services Agreement with Boston Children's Hospital
  • TS Alliance: Clinical Research Consortium
  • The Roles of Race, Racism, And Neighborhood Health in Outcomes of Pediatric Lupus
  • Understanding COVID-19 Among Critically Ill Children in the Pediatric Acute Lung Injury and Sepsis Investigator's (PALISI) Network